According to Dyne Therapeutics's latest financial reports the company has โฌ0.70 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โฌ0.11 B | -53.34% |
2022-12-31 | โฌ0.23 B | -28.22% |
2021-12-31 | โฌ0.33 B | 18.44% |
2020-12-31 | โฌ0.28 B | 2049.39% |
2019-12-31 | โฌ13.06 M | 83.93% |
2018-12-31 | โฌ7.1 M |